National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Drugs
:
U
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
R
S
T
U
V
Z
Ulipristal acetate (Esmya ®) intermittent treatment
Ulipristal acetate (Esmya®) single course treatment
Umeclidinium/vilanterol (Anoro®)
Upadacitinib (Rinvoq®) for ankylosing spondylitis. HTA ID: 21039
Upadacitinib (Rinvoq®) for atopic dermatitis. HTA ID: 21029
Upadacitinib (Rinvoq®) for psoriatic arthritis. HTA ID: 21040
Upadacitinib (Rinvoq®) HTA ID: 19047
Upadacitinib (Rinvoq®). HTA ID: 22047
Urea (GlucoRx Allpresan®)
Ustekinumab (Stelara®)
1
2
Next Page
health check